Close
Digital Health & Ai Innovation summit 2026
APE 2026

Covidien introduces Plus Bladeless Trocar line for the minimally invasive surgical market

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Spinoff from 3M Health Care Acquires...

Solventum went ahead and shared on December 23, 2025,...

Fulgent Eyeing Bako, StrataDx for its...

Fulgent Genetics has inked a definitive agreement so as to...

Edwards Gets FDA Nod for Sapien...

In recent news, Edwards Lifesciences has gone on to win...
Covidien, a leading global provider of healthcare products, announced that its Surgical Devices business unit has launched the Versaport(TM) Plus Bladeless Trocar line for the minimally invasive surgical market worldwide.

Covidien, a leading global provider of healthcare products, announced that its Surgical Devices business unit has launched the Versaport(TM) Plus Bladeless Trocar line for the minimally invasive surgical market worldwide.

The Versaport(TM) Plus Bladeless Trocars offer surgeons greater precision and control, low insertion force, a small facial defect and superior port fixation with Covidien's proprietary secure entry technology. When the Versaport(TM) Plus Bladeless Trocar is combined with Step(TM) technology in VersaStep(TM) Plus, Covidien sets the standard for safety in laparoscopic entry and provides medical professionals with a comprehensive line of bladeless access devices.

Scott Flora, President, Surgical Devices, Covidien said, Our innovative Versaport(TM) Plus Bladeless Trocars are the latest example of Covidien's collaboration with customers to offer access solutions that give them the sense of confidence, security and control that they have been asking for. This product launch, when coupled with some of our current technologies, significantly enhances our position in the rapidly growing market for bladeless access devices and trocars.

Versaport(TM) Plus Bladeless Trocars can be used in conventional and advanced laparoscopic procedures in general, bariatric, colon and rectal, gynecological and urological surgery.

Latest stories

Related stories

Spinoff from 3M Health Care Acquires Acera Surgical

Solventum went ahead and shared on December 23, 2025,...

Fulgent Eyeing Bako, StrataDx for its Lab Services Business

Fulgent Genetics has inked a definitive agreement so as to...

Edwards Gets FDA Nod for Sapien M3 Mitral Valve Replacement System

In recent news, Edwards Lifesciences has gone on to win...

Abbott to Enter U.S. PFA Market with Volt PFA System

Abbott is soon going to enter the competitive U.S....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »